Skip to main content
Download PDF

Experiences of using a digital tool, the D-foot, in the screening of risk factors for diabetic foot ulcers

Journal of Foot and Ankle Research volume 15, Article number: 90 (2022) Cite this article

Abstract

Background

Individuals living with diabetes run an increased risk of developing diabetic foot ulcers (DFUs), leading to high costs to society and reduced quality of life for the individual. Regular screening is important to avoid complications.

Aim

To evaluate patients’ and clinicians’ experiences of using a digital tool, the D-Foot, in the screening of risk factors for developing DFUs. The secondary aims were to investigate whether patients had had their feet examined by a nurse or doctor during the past year, had been referred to podiatry and whether patients had received information about self-care.

Methods

A prospective study was carried out, comprising 90 patients with diabetes visiting a Department of Prosthetics and Orthotics (DPO). Two Certified Prosthetists and Orthotists (CPOs) were included, and they assessed foot status and the risk of developing DFUs with the D-Foot software, prior to prescribing footwear. The quality of services at the DPO was assessed by the patients using the Orthotics and Prosthetics Users’ Survey (OPUS). The CPOs answered the System Usability Scale (SUS) before and after the study to assess the usability of the D-Foot.

Results

No patient had risk grade 1. One (1%) patient had risk grade 2, 78 (87%) patients had risk grade 3 and 11 (12%) patients had risk grade 4. Patients reported high levels of satisfaction on eight of ten OPUS items and the two items with lower scores were not related to the use of the D-Foot. The two CPOs reported levels above the mean regarding usability both before (77.5 and 90) and after (70 and 97.5) using the D-Foot.

Conclusions

Patients expressed a high level of satisfaction with the services when their feet were examined with the D-Foot prior to the provision of footwear. The CPOs found that the D-Foot system was usable. Several comments were made by patients and CPOs and will support the future development and testing of the D-Foot. There is a need to increase referrals for preventive podiatry and improve information on self-care for patients at risk of DFUs.

Trial registration

ClinicalTrials.gov ID: NCT04054804.

Peer Review reports

Background

Individuals living with diabetes run an increased risk of developing complications such as diabetic foot ulcers (DFUs) and this complication might lead to an amputation [1]. In 2021, the total number of patients at risk of developing DFUs was estimated at 270 million globally [2] and 250,000 in Sweden [3,4,5], given that 50% of the patients have peripheral neuropathy [6, 7]. DFUs are associated with poor quality of life [8] and high costs; the annual cost/DFU has been estimated at 19,000 US$ (around 110,000 SEK) [9,10,11]. The prevention of DFUs is essential to preserve the quality of life of patients and reduce healthcare costs to society [12,13,14]. The prevention of DFUs should include: 1) regular screening for risk factors for developing DFUs, 2) intervention with prescribed footwear (shoes and/or insoles), 3) podiatry and 4) patient self-care education [15,16,17,18]. As stated by the World Health Organisation, therapeutic footwear is necessary for persons with diabetes with peripheral neuropathy and risk factors for developing DFU. Prescribed footwear is one of 50 assistive devices that should be available for those in need, as recommended by the World Health Organisation in the Priority Assistive Products List [19].

The opportunities for introducing new clinical examination methods, such as a digital tool, need to consider how the healthcare system is organised and the laws, regulations and guidelines when examining and prescribing assistive devices to patients with diabetes at risk of developing DFUs [20]. Some of the laws that form care in Sweden are: a) the patient law that states that care should be patient centred and that healthcare professionals should have a dialogue with the patient regarding examination, treatment and a care plan [21] and b) the law relating to the need to consider the integrity of the patient when data are registered in the medical record systems [22, 23]. These laws aim to promote the patient’s integrity, self-determination and participation and must be followed by all healthcare professionals [22, 23]. When implementing new eHealth systems, the European regulations regarding the development and maintenance of a medical product need to be followed [24].

Starting in 2010, the D-Foot was developed by healthcare professionals, patients and researchers in Sweden with the aim of: 1) facilitating foot screening, 2) generating an objective risk stratification (1 = no risk, 2 = low risk, 3 = medium risk and 4 = ongoing DFU) and 3) individualising care and advice regarding self-care with the aim of promoting good foot health and preventing DFUs. A detailed description of the D-Foot is presented in the method section. The D-Foot was designed to be used primarily by clinicians working at DPOs [25] and secondarily by other healthcare professionals to improve the care of patients at risk of developing DFUs [26, 27].

It has been suggested that digital tools, such as the D-Foot, improve DFU management in care [28,29,30,31] and stored data can be useful when auditing the care of DFU patients to support clinical improvements, as presented by Leese et al. [30]. Continuous improvements based on the users’ experiences to develop and implement improvements are necessary [32, 33].

The primary aim of the study was to evaluate the users’ experiences of using the D-Foot in the screening of risk factors for developing DFUs. The secondary aims were to investigate whether patients had had their feet examined by a nurse or doctor during the past year, had received podiatry and whether the patient had been given information about self-care.

Methods

Study design and procedure

This prospective study was carried out in 2019 in a cohort of patients with diabetes referred to the DPO at Sahlgrenska University Hospital in Gothenburg, Sweden. The purpose of the visit to the DPO was to provide the patient with pressure-relieving footwear, insoles together with shoes, to counteract the occurrence of DFU. The referred patients were contacted by phone and patients interested in participating in the study were informed by the principal investigator and received an invitation letter to the DPO, Fig. 1. The letter included information on how to answer the patient questionnaire in the D-Foot, Additional file 1. The second way for the patients to answer this questionnaire was at the DPO, where the survey was visualised on a tablet (Samsung Galaxy Tab. A 10.1). The patients’ answers were registered before the clinical examination began. If needed, the investigator helped the patients to register their answers on the tablet. The clinical examinations were assessed by one of two CPOs, at the DPO, following the routine in the D-Foot. The daily clinical work process in the prescription is as follows: a) the CPO evaluated the patients’ need for prescribed footwear, b) suggested and discussed a care plan with the patient, c) gave self-care advice and d) provided the patient with footwear as described in clinical guidelines [35]. The information, advice and provision of footwear were based on the patient’s risk of developing DFUs according to the D-Foot examination. Finally, the D-Foot assessment summary was printed out as a PDF report and given to the patient. The footwear was delivered either on the first visit or on a second visit to the DPO, two to 8 weeks later, Additional file 9.

Fig. 1
figure 1

A visualisation of the different steps in the study. Note: OPUS; Orthotics and Prosthetics Users’ Survey (OPUS) [34]

Full size image

The CPOs documented the assessments, tests, care plan decisions and the information they gave to patients in the local EMR system, Pilot, used at the DPO situated in Region Västra Götaland, Sweden.

The patients’ experiences of the visit to the DPO and the D-Foot examination were evaluated using the Orthotics and Prosthetics Users’ Survey (OPUS) [34]. The survey was filled in after the patients had been provided with their prescribed footwear. The users’ experiences of using the D-Foot were explored by registering the users’ (patients and CPOs) comments as they used the D-Foot at the DPO, Fig. 1. The method used was the think-aloud method, a method frequently used in usability testing where the spontaneous comments from the users are registered, in this case the patients and CPOs [36]. The registration was made by the principal investigator.

The CPOs’ expectations and experiences of using the D-Foot were evaluated using the System Usability Scale (SUS), before and after the study period.

Study sample – CPOs

Two experienced CPOs at the DPO at Sahlgrenska University Hospital agreed to participate in the study. They were skilled in prescribing footwear to patients at risk of developing DFUs with assistive devices and had worked as CPOs for nine and 20 years respectively.

Before the start of the study, each CPO completed a D-Foot introductory course which lasted for 2 h on two separate occasions. Moreover, the CPOs participated in a workshop with the purpose of becoming familiar with the D-Foot examination routine.

The D-foot software

The D-Foot software has seven functions: 1) a booking system to schedule patients’ appointments, 2) a questionnaire to be answered by patients, 3) examinations to be completed by a healthcare professional, Additional files 2, 4) a system for generating a risk classification for each patient, Additional files 3, 5) a summary as a PDF report, 6) a database containing all registered information and 7) an administration part licensing the CPOs to obtain access to the program [25]. A brief description of some different components included in the D-Foot is also included in Additional file 4 and a summary in Additional file 10. A detailed description has been presented in a previous study by Hellstrand Tang et al. [25]. Based on the results from the previous study, the users (eight CPOs) [25] suggested refinements as compared with the first version. The following improvements were therefore made: 1) adding a test of signs of peripheral angiopathy with the question “Has a healthcare professional confirmed that you have peripheral angiopathy?”, 2) excluding the navicular drop test [37], 3) excluding the test entitled “Can you extend and flex you toes”, 4) excluding the question of whether the foot had areas of excessive pressure with calluses, 5) excluding the assessment “Gait deviation, affected from hip/knee joint” and 6) splitting the assessment of Charcot foot (acute Charcot foot and manifest deformed Charcot foot) [25].

Furthermore, in the current version, the order of the assessment was reorganised to fit more effectively into a more clinical flow with the patient being examined first in a sitting position, followed by standing assessments.

Based on the patients’ answers in the survey and the assessment made by the CPO, a risk classification (1–4) was generated according to the national risk classification system [26, 38], Additional file 3. In this risk classification, the symptoms that are related to each of the risk categories are presented: peripheral neuropathy/angiopathy, foot deformities, skin pathologies, previous DFU/amputation, active DFU/Charcot deformity and/or severe pain syndrome. The risk classification, together with the recommended interventions, such as podiatry, footwear, and regular foot examinations, was automatically displayed on the screen of the tablet and was also included in the PDF report that was given to the patient. Finally, the CPO copied the results from the D-Foot and pasted them into the patient’s EMR and, in addition, all the data were stored in a separate D-Foot database. The reliability and validity of the D-Foot software have previously been presented by Hellstrand et al. [25].

Equipment

The CPOs recorded their findings on a laptop. Patients answered the patient questionnaire using a smart phone, tablet, or personal computer. A goniometer was used to measure passive maximum dorsal flexion at the metatarsal phalangeal joint and passive dorsiflexion at the ankle joint, as previously described by Hellstrand Tang et al. [25]. A foot calliper was used to measure foot length and foot width, while toe height was measured with a ruler [25], Additional file 4.

Questionnaire – patients

The patients answered the Swedish version of the Client Satisfaction with Services module of the OPUS after they had received their footwear. The OPUS module assesses patients’ experiences of the service quality and has been validated with Swedish patients at DPOs [34]. The 10 items are answered on a three-level Likert scale (disagree = 1, agree = 2 and strongly agree = 3) and were analysed by calculating the mean and standard deviation for each question. The OPUS questionnaire is recommended by the Swedish Orthotic and Prosthetic industry advisory council to evaluate patient satisfaction with the services at DPOs located in Sweden [39].

Questionnaire – CPOs

In connection with the start of the study, a Swedish version of the System Usability Scale (SUS) was answered by the CPOs to capture their expectations of using the D-Foot in clinical work, Additional file 5. The SUS consists of 10 questions answered on a five-level Likert scale (from strongly disagree = 1, to agree completely = 5) and is a reliable tool for measuring usability [40]. At the end of the study, the CPOs answered the SUS a second time to assess their experiences of using the D-Foot, Additional file 6. These answers were transformed to a 0–100 scale, where a higher score indicates a higher level of usability.

In addition, at the end of study, the CPOs answered a study-specific questionnaire on how they had experienced the digital foot examination, what information they had given to the patients and how long it took for the CPOs to execute different sequences of the examination, Additional file 7. The questions on time estimations were related to how long it took to: 1) finalise the patient appointment and foot assessment when the D-Foot routine was used (< 30 min., 31–45 min., 46–60 min., > 60 min), 2) make the medical recording based on the D-Foot examination (< 6 min., 6–10 min., 11–15 min., 16–20 min.) and 3) order their prescribed footwear (< 6 min., 6–10 min., 11–15 min., 16–20 min.), Additional file 8.

Statistics

Descriptive statistics were used to present patient demographics. The mean and standard deviation were calculated for continuous variables. Differences between the included patients and the non-included patients were compared with an independent t-test for age and Pearson’s chi-square test for gender. IBM SPSS Statistics for PC, Version 25, was used for all statistical calculations.

Results

Study sample – patients

Patients on the waiting list, n = 107, at the DPO, Sahlgrenska University Hospital, with a referral to prevent foot complications in diabetes, were invited to participate in the study. The inclusion criteria were being diagnosed with diabetes, age ≥ 18 years and understanding the Swedish language.

The studied group finally consisted of 90 patients, 53 men and 37 women, with a mean age of 68 ± 13 years. The patients who were not included (n = 17), nine men and eight women, had a mean age of 64 ± 15 years and did not differ significantly from the included participants according to gender (p = 0.65) and age (p = 0.27). Of the entire group, 57 patients had retired and 17 were working, Table 1.

Table 1 Descriptive data of included patients
Full size table

The examination showed that no patient had risk level 1, one (1%) patient had risk level 2, 78 (87%) patients had risk level 3 and 11 (12%) patients had risk level 4. At the examination, the patients were asked about the interventions to prevent DFU they had received. Seventy-eight (87%) patients had had their feet examined by a nurse or doctor during the past year, 59 (66%) answered that they had received podiatry and 59 patients (66%) had been given information about the self-care of their feet.

Orthotics and prosthetics users’ survey-OPUS

Eighty-two (91%) of 90 patients answered OPUS. The mean value of the questions ranged from 2.3 to 2.9, where 2 = agree and 3 = strongly agree, Table 2. Satisfaction with services was highest for the questions related to how the CPOs showed courtesy and respect, how the patients were informed about the choice of footwear and the opportunity to express their own concerns. Satisfaction was lowest for the waiting time for the appointment and the co-ordination of services.

Table 2 Results from the orthotic and prosthetics users’ survey (n = 82)
Full size table

System usability scale

One CPO had an SUS score of 77.5 before using the D-Foot and 70.0 after the study was completed. The second CPO had an SUS score of 90.0 before using the D-Foot and 97.5 after the study was completed, Table 3.

Table 3 Results from the System Usability Scale (SUS) answered by two CPOs
Full size table

Comments and feedback from patients and CPOs

In total, 147 comments were registered, (n = 50 from patients and n = 97 from CPOs), Table 4. Overall, 55 comments were related to improvements (n = 26 from patients and n = 29 from CPOs). Patients suggested refinements to the patient questionnaire regarding the perceptions of neuropathy; pain, previous ulcers, sweat and HbA1c. Patients found questions such as “Have you had a foot ulcer? and “Are your feet less sweaty now compared with recent years?” difficult to answer. Patients suggested specifying the question of “Have you previously had hard-to-heal ulcers?” and removing the question about sweaty feet, because some patients said that they had never had sweaty feet. Further, they suggested expanding the question on the sensation of tingling or numbness to include sensations of cramp, walking on pillows and feelings such as “it feels like a band around my foot”. The question about the presence of pain should be more specific, such as “How much pain have you experienced in your feet during the past week”.

Table 4 Summarised comments (n = 51) from the patients and the CPOs registered as they used the D-Foot
Full size table

Other suggested improvements, coming from both patients and CPOs, were to design the PDF report in an easy-to-understand format with larger text, linking the risk grade to each of the specific risk factors and, in addition, creating customised information and advice about self-care of the feet for patients. Requests were also made to be able to post the report in digital format in addition to the printable version. The individual risk factors should be linked to the recommended treatment (e.g. recommendation to use a high toe box in the presence of hammer toes). Moreover, digital referrals to other healthcare professionals, based on the results, should be included in upcoming versions.

The CPOs requested integration with co-working systems, such as the population register, the EMR used by other healthcare professionals and the EMR used at the DPO. Loss of wi-fi, breakdown of the EMR at the DPO and problems registering findings in the D-Foot system were registered. Eleven patients were not booked in the D-Foot system and these patients were therefore unable to answer the patients’ questions at home, prior to the visit.

Of the 90 patients, 18 (20%) answered the patient survey prior to the visit to the DPO and 72 (80%) answered the survey on a tablet at the visit. More than 50% (n = 44) were helped at the DPO to answer the survey.

CPOs’ experiences of the digital foot examination and information to the patient

The CPOs felt that they had provided “complete” information regarding a) how patients should perform self-care for their feet, b) where patients could obtain additional information, c) potential risks when using the assistive device and d) warning signs relating to health and the assistive device. Regarding the questions: a) whether the examination took place in privacy, b) information on the D-Foot results and c) whether the patient had received oral and written information about the assistive device, they were judged to have been performed “completely”. Two questions were judged to be less well fulfilled by one of the CPOs: a) the discussion of the health condition and b) whether the results of the D-Foot survey were explained in a way the patient understood, Table 5.

Table 5 Answers from the certified prosthetists and orthotists
Full size table

The estimated time required for different sequences when meeting the patients was assessed equally by the two CPOs. The time required for the patient appointment was 40–60 minutes. Writing the medical record took six to 10 minutes and ordering shoes and materials took six to 10 minutes. The patient’s visit was finalised within a total of 52–80 minutes.

Discussion

This is the first implementation study of a digital screening tool, the D-Foot, and we found that patients were generally satisfied with the services when being routinely examined using the D-Foot. The CPOs found the D-Foot software usable. It is worth noting that one third of the patients reported that they had not received podiatry or received information about foot self-care, which is concerning.

The patients generally expressed a high level of satisfaction with the services at the DPO when using the D-Foot for the foot examination. It is worth noting that not all the OPUS items relate to the foot examination and the two items with the lowest scores (waiting times and co-ordination of services) relate to the items that were not related to the foot examination and the use of the D-Foot.

The usability, according to the SUS, was generally high both before and after using the D-Foot, as scores above 68 can be regarded as “above average” [40, 41]. For one CPO, the SUS score improved by 7.5 points after having used the D-Foot, indicating that this CPO found the D-Foot’s usability better than he had expected prior to using it. For the other CPO, the SUS score deteriorated by 7.5 points after having used the D-Foot. This is most likely explained by technical problems with the wi-fi system. However, on individual items, most ratings were similar before and after using the D-Foot. Only two ratings by one of the CPOs changed by more than one step on the rating scale. One expectation changed in both the positive and negative direction after the CPOs had used the D-Foot. One CPO responded more positively (from 5 = strongly agree to 2 = do not agree) regarding “I think that I will need the support of a technical person to be able make a digital assessment”, indicating that, by using the D-Foot, the need for technical support decreased. Several other questions were scored positively both prior to and after use, such as the D-Foot was easy to use, it was quick to learn, and the user felt confident about using the D-Foot.

A variety of comments were collected from the CPOs and these comments from users are useful in the continuous improvement of digital tools such as the D-Foot software [32]. In future versions, the authors suggest that improvements should be made. For example, to specify the question regarding pain as “How much pain as a mean value did you perceive last week in your right foot”, followed by a Likert scale. Furthermore, a more easy-to-understand report, with custom-made information regarding footwear and self-care, would make it easier for persons with diabetes to perform self-care based on their individual risk factors. The report should be available in both a printed and a digital version, with the option of being sent to the patient.

Continuous improvements, based on the needs of different healthcare users, are a necessity, as described by Koltveit et al., when implementing digital tools in the care of DFUs [33]. The authors suggest that digital tools, such as the D-Foot, are useful when implementing seamless and person-centred care for persons living with diabetes with a risk of foot complications, as recommended by the Swedish Association of Local Authorities and Regions [42].

Several improvements were suggested by the patients and CPOs, such as clarifying and differentiating the patients’ questions and facilitating the booking system by connecting the D-Foot to the population register. Patient security and integrity will definitely be improved by integration with the population register. This would ensure that the right patient with the right identity is booked in the D-Foot system. Integration with the EMR used by other healthcare professionals would lead to data being available where the patient is treated: in primary care, in specialist care or at the DPO. Moreover, with integration between systems, digital referrals and responses to referrals would improve communication, thereby improving the quality of care. To summarise, the D-Foot is useful for CPOs and would improve the quality of care without requiring more time for each visit.

Unstable wi-fi is a concern, as presented in this study. In addition to developing functioning software, the D-Foot, the DPOs need to assure that wi-fi is in place.

Secondly, the use of the stored D-Foot is useful for audit and follow-up at local, regional and national level and fills a gap identified in national guidelines [20].

A default value of “no risk factor” was suggested by one CPO as a way of facilitating the CPOs’ assessment. If a risk factor is present, the CPO registers this specific risk factor.

Patient satisfaction with the service at the DPO revealed relatively high scores according to the results from OPUS. Two questions were answered as “not applicable” and the reason might be that patients do not regard footwear (insoles and shoes) as assistive devices. This semantic question needs to be clarified and specified as shoes and insoles, to avoid misunderstanding.

One limitation of the study was that no control group of patients who received traditional examination of the feet was used. As a result, it is not possible to determine the extent to which the patients’ high level of satisfaction with the services was due to the use of the D-Foot or to the general appreciation of the services at the DPO. Only two CPOs were included, limiting the interpretations of the CPOs’ answers regarding the SUS. A larger sample is recommended in future studies. The two CPOs only answered a study-specific questionnaire at the end of the study. This evaluation, Appendix 4, should preferably be carried out after each D-Foot assessment made for each of the participants. This could not be carried out after each patient, due to the daily CPO-scheduled work. Finally, the study was conducted at a single DPO, which limits the generalisability of the results, and future studies should include CPOs at different locations.

Conclusion

Patients with diabetes expressed a high level of satisfaction with the services when their feet were examined following the routine in the D-Foot software prior to the provision of footwear. The CPOs felt that the D-Foot system was usable. Several comments were made by patients and CPOs and will support the future development of and improvements to the D-Foot software. The current study revealed that not all patients in need had access to preventive interventions such as podiatry and information about self-care.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author in response to a reasonable request, if the appropriate permits are obtained from the correct authorities.

Abbreviations

DFUs:

Diabetic foot ulcers

DPO:

Department of Prosthetics and Orthotics

CPOs:

Certified Prosthetists and Orthotists

OPUS:

Orthotics and Prosthetics Users’ Survey

SUS:

System Usability Scale

EMR:

Electric medical recording

US$:

US dollar (USD)

SEK:

Swedish krona

References

  1. Edmonds M, Manu C, Vas P. The current burden of diabetic foot disease. J Clin Orthop Trauma. 2021;17:88–93.

    Article  Google Scholar 

  2. International Diabetes Federation: IDF diabetes atlas 2021. 2022.

    Google Scholar 

  3. Hellstrand S, Hellstrand Tang U. A new approach to quantifying the sustainability effects of healthcare: applied to the diabetic foot. Foot Ankle Online J. 2019;12(3):5.

  4. Hellstrand Tang U. The diabetic foot - assessment and assistive devices. Diss (sammanfattning) Göteborg: Göteborgs universitet; 2017.

    Google Scholar 

  5. The Swedish National Diabetes Register: Annual report 2021. 2021. Available at: https://www.ndr.nu/#/arsrapport. Accessed 12 Dec 2022.

  6. Kärvestedt L, Mårtensson E, Grill V, Elofsson S, Von Wendt G, Hamsten A, et al. The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden. J Diabetes Complicat. 2011;25:97–106.

    Article  Google Scholar 

  7. Lu B, Yang Z, Wang M, Yang Z, Gong W, Yang Y, et al. High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract. 2010;88:289–94.

    Article  Google Scholar 

  8. Khunkaew S, Fernandez R, Sim J. Health-related quality of life among adults living with diabetic foot ulcers: a meta-analysis. Qual Life Res. 2019;28:1413–27.

    Article  Google Scholar 

  9. Hellstrand S, Sundberg L, Karlsson J, Zugner R, Tranberg R, Hellstrand Tang U. Measuring sustainability in healthcare: an analysis of two systems providing insoles to patients with diabetes. Environ Dev Sustain. 2020;23:1–15.

    Google Scholar 

  10. Ragnarson Tennvall G, Apelqvist J. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia. 2001;44:2077–87.

    Article  CAS  Google Scholar 

  11. Ragnarson Tennvall G, Apelqvist J, Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics. 2000;18:225–38.

    Article  Google Scholar 

  12. Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T. A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res. 2007;16:179–89.

    Article  Google Scholar 

  13. Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complicat. 2000;14:235–41.

    Article  CAS  Google Scholar 

  14. International Diabetes Federation: Clinical practice recommendations on the diabetic foot – 2017. 2017.

    Google Scholar 

  15. Handbook for prescribing personal aids. https://www.vgregion.se/halsa-och-vard/vardgivarwebben/vardriktlinjer/hjalpmedel/handbok-for-forskrivig-av-personliga-hjalpmedel/.

  16. IWGDF Guidelines. https://iwgdfguidelines.org/guidelines/.

  17. Bus SA, Armstrong DG, Gooday C, Jarl G, Caravaggi C, Viswanathan V, et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36:e3274.

    Google Scholar 

  18. Bus SA, Lavery LA, Monteiro-Soares M, Rasmussen A, Raspovic A, Sacco ICN, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3269.

    Google Scholar 

  19. Priority Assistive Products List. https://www.adcet.edu.au/resource/9364/who-priority-assistive-products-list#:~:text=The%20World%20Health%20Organisation%20%28WHO%29%20Priority%20Assistive%20Products,to%20live%20a%20healthy%2C%20productive%20and%20dignified%20life.

  20. Sweden’s Municipalities and Regions: Person-centred and coherent care course Diabetes with a high risk of foot ulcers. 2022.

    Google Scholar 

  21. Socialdepartementet. Patient law (SFS 2014:821): Socialdepartementet; 2014.

    Google Scholar 

  22. Ministry of Social Affairs: Patient Data Law (SFS 2008:355). 2008.

    Google Scholar 

  23. Information management and record keeping in health care (SOSFS 2008:14). http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/8560/2008-10-14.pdf.

  24. EU: Medical device regulation 2017/745. 2017.

  25. Hellstrand Tang U, Tranberg R, Zügner R, Karlsson J, Lisovskaja V, Siegenthaler J, et al. The D-foot, for prosthetists and orthotists, a new eHealth tool useful in useful in risk classification and foot assessment in diabetes. Foot and Ankle Online J. 2017;10(2):4.

  26. Sweden’s Municipalities and Regions: Foot examination in diabetes - National care program for the prevention of foot complications in diabetes. (Östensson C-G, Johansson K, Insulander L, Jonsson LV, Löndahl M, Sergu-Bogdan C, Jansson S, Gustafsson S, Hellstrand Tang U eds.); 2018.

  27. National Board of Health and Welfare. National guidelines for diabetes care: Indicators. Bilaga; 2018.

    Google Scholar 

  28. Praxel TA, Ford TJ, Vanderboom EW. Improving the efficiency and effectiveness of performing the diabetic foot exam. Am J Med Qual. 2011;26:193–9.

    Article  Google Scholar 

  29. Leese GP, Stang D. When and how to audit a diabetic foot service. Diabetes Metab Res Rev. 2016;32(Suppl 1):311–7.

    Article  Google Scholar 

  30. Leese GP, Stang D, McKnight JA. A national strategic approach to diabetic foot disease in Scotland: changing a culture. Br J Diabetes Vasc Dis. 2011;11:69–73.

    Article  Google Scholar 

  31. Greenhalgh T. How to improve success of technology projects in health and social care. Public Health Res Pract. 2018;28(3):2831815.

    Article  Google Scholar 

  32. Scandurra I, Hagglund M, Persson A, Ahlfeldt RM. Disturbing or facilitating? - on the usability of Swedish eHealth systems 2013. E Health Continuity of Care. 2014;205:221–5.

    Google Scholar 

  33. Kolltveit B-CH, Gjengedal E, Graue M, Iversen MM, Thorne S, Kirkevold M. Conditions for success in introducing telemedicine in diabetes foot care: a qualitative inquiry. BMC Nurs. 2017;16:2–2.

    Article  Google Scholar 

  34. Jarl GM, Heinemann AW, Norling Hermansson LM. Validity evidence for a modified version of the orthotics and prosthetics Users' survey. Disabil Rehabil Assist Technol. 2012;7:469–78.

    Article  Google Scholar 

  35. National Board of Health and Welfare: Prescription of assistive devices. 2016.

    Google Scholar 

  36. Payne JW. Thinking aloud: insights into information processing. Psychol Sci. 1994;5:241–8.

    Article  Google Scholar 

  37. Nielsen RG, Rathleff MS, Simonsen OH, Langberg H. Determination of normal values for navicular drop during walking: a new model correcting for foot length and gender. J Foot Ankle Res. 2009;2:12.

    Article  Google Scholar 

  38. National Diabetes Registry: Annu Report 2019. 2020.

  39. The Orthopedic Industry Council. https://ot-branschen.se/.

  40. Bangor A, Kortum PT, Miller JT. An empirical evaluation of the system usability scale. Int J Hum Comput Interact. 2008;24:574–94.

    Article  Google Scholar 

  41. Measuring usability with the system usability scale. https://measuringu.com/sus/.

  42. National clinical knowledge support. https://kunskapsstyrningvard.se/kunskapsstyrningvard/kunskapsstod/omvarakunskapsstod/nationelltklinisktkunskapsstod.44269.html.

  43. World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–4.

    Article  Google Scholar 

Download references

Acknowledgements

We are most grateful for all the support from the patients and staff at the Department of Prosthetics and Orthotics at Sahlgrenska University Hospital. Statistician Christer Johansson contributed his skills, experience and knowledge and the group are most thankful for all support.

Funding

Open access funding provided by University of Gothenburg. This research was supported by Familjen Knut & Ragnvi Jacobssons stiftelse, Innovationsplattformen in the Västra Götaland Region, Stiftelsen Promobilia, Stiftelsen Skobranschens Utvecklingsfond, the Research and Development Council of the County of Göteborg and Södra Bohuslän, the Health & Medical Care Committee of the Västra Götaland Region, Stiftelsen Felix Neubergh, Stiftelsen Gunnar Holmgrens Minne, IngaBritt & Arne Lundbergs Forskningsstiftelse, Adlerbertska forskningsstiftelsen, Diabetesfonden, the Gothenburg Diabetes Association (Inger Hultman med fleras fond and Utvecklingsfonden), Sveriges Ortopedingenjörers Förening, Greta och Einar Askers Stiftelse, Hans Dahlbergs stiftelse för miljö och hälsa and Vinnova.

Author information

Authors and Affiliations

  1. Department of Orthopedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University, SE-413 45, Göteborg, Sweden

    Roland Zügner & Ulla Hellstrand Tang

  2. Forskningsenhet Ortopedi, Göteborgsvägen 31, SE-431 80, Mölndal, Sweden

    Roland Zügner

  3. Department of Prosthetics and Orthotics, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

    Gustav Jarl

  4. University Health Care Research Centre, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

    Gustav Jarl

  5. Gothenburg Diabetes Association, Gothenburg, Sweden

    Leif Sundberg

  6. Department of Prosthetics and Orthotics, Sahlgrenska University Hospital, Gothenburg, Sweden

    Ulla Hellstrand Tang

Authors
  1. Roland Zügner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gustav Jarl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leif Sundberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ulla Hellstrand Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RZ and UHT conceived this study. UHT undertook the statistical analysis. RZ and UHT interpreted the data. RZ, UHT, GJ and LS developed the manuscript. RZ, UHT, LS and GJ critically revised the manuscript and approved the final manuscript for publication.

Corresponding author

Correspondence to Roland Zügner.

Ethics declarations

Ethical approval and consent to participate

The study was approved by the ethical review board in Gothenburg, reference number: 2019–01039. All the patients and the CPOs received oral and written information about the study and their right to withdraw from the study at any time without explanation. The patients and CPOs signed a written consent after they had received verbal and written information. The study was carried out in accordance with the Code of Ethics of the World Medical Association, the Declaration of Helsinki, for experiments involving humans [43].

Consent for publication

Not applicable.

Competing interests

GJ is a consultant for Novo Nordisk. The other authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1. 

 Patient survey included and programmed in the D-Foot.

Additional file 2. 

Examples of different steps in the D-Foot examination.

Additional file 3. 

Prevention and multidisciplinary service (MDS) of foot complications in diabetes.

Additional file 4.

Additional file 5. 

System Usability Scale answered prior to the study.

Additional file 6. 

System Usability Scale answered after the study.

Additional file 7. 

Questions related to the information the certified prosthetist and orthotist gave to the patients and questions related to integrity and time to finalise the visit.

Additional file 8.

Additional file 9.

Additional file 10.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zügner, R., Jarl, G., Sundberg, L. et al. Experiences of using a digital tool, the D-foot, in the screening of risk factors for diabetic foot ulcers. J Foot Ankle Res 15, 90 (2022). https://doi.org/10.1186/s13047-022-00594-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13047-022-00594-9

Keywords

Journal of Foot and Ankle Research

ISSN: 1757-1146